Thursday, May 19, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Characteristics of viral infection super-spreaders

by Medical Finance
in Coronavirus
Study: Do Some Super-Spreaders Spread Better? Effects of individual heterogeneity in epidemiological traits. Image Credit: Woeywoey/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

In a recent study posted to the medRxiv* preprint server, researchers evaluated whether certain super-spreaders transmit viral infection better and the impacts of individual variance in epidemiological characteristics. 

Study: Do Some Super-Spreaders Spread Better? Effects of individual heterogeneity in epidemiological traits. Image Credit: Woeywoey/Shutterstock

Study: Do Some Super-Spreaders Spread Better? Effects of individual heterogeneity in epidemiological traits. Image Credit: Woeywoey/Shutterstock

Background

Super-spreading is at the root of several high-profile outbreaks, including Ebola, the Middle East respiratory syndrome (MERS), human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Although super-spreading is an unchangeable aspect of epidemics, the relative contribution of two super-spreaders to the fate of an epidemic and the features that contribute to super-spreading at the personal level are unclear. 

For instance, although an individual’s high contact rate or low recovery rate may contribute disproportionately to transmission, it is unknown how these super-spreaders differ in their influences on epidemiological dynamics. Further, epidemiological features frequently correlate with one another, promoting or inhibiting super-spreading. Nevertheless, there is limited data regarding trends of covariation and covariation between which traits are most likely to lead to massive epidemics caused by super-spreading.

About the study 

In the present study, the researchers assessed how covariation and variation between characteristics linked with disease transmission (infectiousness and contact rate) and duration (recovery and virulence) of virus-infected people influenced peak epidemic size and super-spreading. The researchers established a stochastic, individual-based variant of a basic susceptible, infectious, or recovered (SIR) model incorporating demography for understanding how heterogeneity affects endemic and epidemic dynamics. 

The team accounted for covariation across all combinations of features linked to duration and transmission to assess if some qualities were more likely to cause larger super-spreading or epidemics occurrences. The investigators then evaluated each model combination at three degrees of variation and three R-naught (R0) values.

The researchers performed 50 stochastic simulations of each model, recording the epidemiological dynamics, the number of secondary infections, and each infected person’s trait values. They examined the heterogeneity in the number of secondary infections and peak epidemic size for each model.

Findings

The study results indicated that increasing variation nearly always leads to a hike in the peak size of the epidemic throughout all simulations. The only time this was less true was when infectiousness and contact covary, yet this was because higher variance increases the risk of epidemic fade-outs, as previous research has shown. As indicated by the reduction in the dispersion parameter, k, higher variation tends to enhance individual heterogeneity in spreading. 

When virulence and recovery covary, the effect of variation was less pronounced. Although the authors observed rising heterogeneity, the distributions of k were widely overlapping, implying that variation has less influence in this case. Interestingly, in the high variation situation, the observed values of k in the present simulations were merely similar to previous empirical estimates.

The impacts of covariation were less significant and were dependent on whether the covarying attributes influenced duration or transmission (intragroup) or both duration and transmission (intergroup) and the overall amount of variation. Covariation only had an effect at the highest degree of variation for intergroup pairings, and the authors reported more super-spreading and large epidemics when attributes covaried negatively or positively. On the other hand, when covariation was positive, the researchers observed large and more variable epidemics in intragroup pairings. 

The authors found that the strongest influence of covariation sign was when transmission attributes covary, with epidemic fade-outs significantly more frequent under negative covariation than positive, specifically at high variation. Further, the impact of covariation and variation was the smallest when duration features covary.

The findings indicate no association existed between the epidemic size and the frequency of super-spreading, contrary to few prior studies. In addition, the scientists did not find that more super-spreading results in higher epidemic peaks. 

Conclusions

The study findings depicted that covariation mattered when infectiousness and contact rate covary. Peak epidemic size was the highest when infectiousness and contact rate positively covary and lowest when these two factors negatively covary. While the authors did not observe a substantial correlation between more super-spreading and larger epidemic, they reported that the association between peak epidemic size and super-spreading depended on which attributes were covarying. These data indicate that the frequency of super-spreading and the epidemic size may not always be related.

The current findings add another layer of complexity to why certain virus-infected people become super-spreaders. Additionally, the researchers warranted further research to determine when covariation between duration and transmission features occurs to improve the capacity to control and forecast super-spreading and epidemics. 

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: A comparison of transmissibility of SARS-CoV-2 Variants of Concern. Image Credit: Lightspring/Shutterstock

Assessing the transmissibility of SARS-CoV-2 variants of concern

by Medical Finance
May 19, 2022
0

A recent study posted to the Research Square* preprint server and currently under consideration at Virology Journal investigated and compared the transmissibility...

Study: The major genetic risk factor for severe COVID-19 is associated with protection against HIV. Image Credit: IR Stone / Shutterstock

Neanderthal gene makes people susceptible to COVID-19, but protects against HIV

by Medical Finance
May 19, 2022
0

A study recently published in the top-tier journal Proceedings of the National Academy of Sciences of the United States of...

The epidemiology of COVID-19 in Africa

The epidemiology of COVID-19 in Africa

by Medical Finance
May 19, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the virus responsible for the coronavirus disease of 2019 (COVID-19),...

Study: Omicron and Alpha P680H block SARS-CoV2 spike protein from accessing cholinergic inflammatory pathway via α9-nAChR mitigating the risk of MIS-C. Image Credit: SciePro/Shutterstock

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

by Medical Finance
May 19, 2022
0

A recent study posted to the bioRxiv* preprint server assessed the mechanism by which severe acute respiratory syndrome coronavirus 2...

Study: Subtyping of major SARS-CoV-2 variants reveals different transmission dynamics. Image Credit: Lightspring/Shutterstock

The transmission dynamics of key SARS-CoV-2 mutations revealed by subtyping in new study

by Medical Finance
May 19, 2022
0

Throughout the course of the current coronavirus disease 2019 (COVID-19) pandemic, there have been several waves attributed to variants of...

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

by Medical Finance
May 19, 2022
0

In a recent study published on the bioRxiv* preprint server, researchers demonstrate that avasimibe (AVS)-mediated inhibition of Acyl-CoA: cholesterol acyltransferase...

Next Post
Scientists unravel how blood cells mount the first line of defense against viruses

Genome research explains why oats could be suitable for most people with celiac disease

Swapping single food item for a more planet-friendly alternative could reduce diet’s carbon footprint

First large-scale estimate of live microbes consumed by Americans daily

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Damaged DNA Festa 8e4e716b43af46eb826e888d544f4cd6 620x480
    Regulation of alternative splicing goes haywire in cells of a newly formed embryo
  • Study: “It affects every aspect of your life”: A qualitative study of the impact of delaying surgery during COVID-19. Image Credit: Photoroyalty/Shutterstock
    Patient-reported impact of having surgery delayed during the COVID-19 pandemic
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply